Schedule 13G ownership disclosure
Sonnet BioTherapeutics Holdings, Inc.
Security class unavailable · CUSIP: 83548R105
Event date: 2020-03-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-20-000082
- Form type
- SC 13G
- Filer
- Ezralow Bryan
- CIK
- CIK 1697957
- Filed
- Apr 08, 2020
- Reporting period
- Mar 19, 2020
- Description
- Schedule 13G beneficial ownership